452 U.S. Pharmaceuticals & Biotech Stocks - Potentially Undervalued Companies - Investing Ideas

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
AQST Aquestive Therapeutics	US$3.90	-0.5%	212.0%	US$387.5m	US$9.00	PS7x	E49.4%	n/a
CRSP CRISPR Therapeutics	US$55.65	0.2%	14.4%	US$4.8b	US$88.13	PS12.7x	E37.6%	n/a
KROS Keros Therapeutics	US$56.24	-5.1%	29.3%	US$2.0b	US$88.11	PS13433.5x	E14.4%	n/a
PSNL Personalis	US$1.30	8.3%	-37.2%	US$70.7m	US$4.75	PB0.5x	E38.0%	n/a
PTGX Protagonist Therapeutics	US$25.70	0.5%	10.5%	US$1.6b	US$43.00	PS25x	E50.0%	n/a
LEGN Legend Biotech	US$45.17	-7.5%	-33.5%	US$8.6b	US$86.33	PS28.8x	E61.0%	n/a
SHC Sotera Health	US$11.32	3.9%	-31.6%	US$3.2b	US$16.75	PE62.7x	E40.3%	n/a
DMTK DermTech	US$0.59	-0.9%	-81.5%	US$21.3m	US$2.04	PS1.3x	E16.5%	n/a
ENTA Enanta Pharmaceuticals	US$12.48	-5.7%	-63.3%	US$273.3m	US$20.88	PS3.6x	E7.8%	n/a
CLVL.F Clinuvel Pharmaceuticals	AU$9.82	3.3%	-24.7%	AU$751.1m	AU$16.77	PE24.9x	E12.9%	0.3%
YCBD cbdMD	US$0.90	-9.9%	-78.9%	US$2.7m	US$2.00	PB0.4x	E107.1%	n/a
TXG 10x Genomics	US$26.90	-7.1%	-47.6%	US$3.3b	US$52.29	PS5.2x	E56.5%	n/a
ACRD.F Acreage Holdings	US$0.38	3.1%	-44.3%	US$64.6m	n/a	PB2.5x	E62.8%	n/a
HKMP.Y Hikma Pharmaceuticals	UK£46.50	0%	-0.8%	UK£4.1b	UK£59.09	PE26.4x	E18.1%	3.2%
SRRK Scholar Rock Holding	US$13.96	0.07%	119.5%	US$1.1b	US$26.25	PB4.9x	E36.9%	n/a
SNDL SNDL	US$1.95	6.6%	32.7%	US$526.2m	US$3.61	PB0.6x	E135.8%	n/a
ALXO ALX Oncology Holdings	US$16.87	7.2%	202.3%	US$819.1m	US$20.17	PB4.5x	E11.5%	n/a
NTRA Natera	US$91.28	4.6%	81.7%	US$11.2b	US$103.12	PS10.3x	E68.7%	n/a
YS YS Biopharma	US$0.80	-7.0%	-48.0%	US$152.5m	US$4.14	PS2x	E58.3%	n/a
TNXP Tonix Pharmaceuticals Holding	US$0.16	1.9%	-94.4%	US$15.3m	US$3.00	PS2x	E31.2%	n/a

U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies